PhytoShield-110: Comprehensive Characterization of a 110-Molecule Supplement as a Potent Anti-Cancer Agent: A Systematic Scientific Investigation

This study hypothesizes that a supplement composed of 110 carefully selected molecules may represent the best anti-cancer agent ever developed. In light of the continuing challenges in oncology—including drug resistance, toxicity, and heterogeneity of cancer—the proposed supplement is designed to harness synergistic interactions among its constituents to maximize efficacy while minimizing adverse effects. Our investigation employs a multidisciplinary approach that integrates in vitro cytotoxicityassays across multiple cancer cell lines, computational modeling (including molecular docking and density functional theory analyses), and in vivo studies. Through rigorous experimental design and comprehensive data analysis, this study aims not only to validate the anti-cancer potency of the supplement but also to elucidate the underlying molecular mechanisms driving its efficacy.